Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis

被引:21
|
作者
Tang, Yingchun [1 ]
Weng, Xiahui [2 ]
Liu, Chang [1 ]
Li, Xing [1 ]
Chen, Chao [1 ]
机构
[1] Eighth Hosp Wuhan, Dept Anorectal Surg, Wuhan 430010, Hubei, Peoples R China
[2] Eighth Hosp Wuhan, Dept Nursing, Wuhan 430010, Hubei, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; PROGRESSION; MIR-19A; MICRORNAS;
D O I
10.1155/2021/4132488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia is a typical microenvironment feature in almost all solid tumors and is frequently associated with growth of cancers including colorectal cancer (CRC). This study focuses on the influence of hypoxic microenvironment on the activity of CRC cells and the molecules involved. CRC cells were cultured under hypoxic conditions for 48 h, after which the proliferation, migration, invasion, and epithelial-mesenchymal transition activities of cells were increased. MicroRNA- (miR-) 19a was significantly upregulated in cells after hypoxia exposure according to a microarray analysis. STAT3 was confirmed as an upstream regulator of miR-19a which bound to the promoter region of miR-19a at the 96 bp/78 bp sites, and miR-19a bound to the PTEN mRNA to activate the PI3K/AKT signaling pathway. Hypoxia exposure induced STAT3 phosphorylation and PTEN knockdown in CRC cells. Silencing of STAT3 reduced the hypoxia-induced activity of CRC cells, whereas the malignant behaviors of cells were restored after miR-19a upregulation but blocked after PTEN overexpression. Similar results were reproduced in vivo where downregulation of STAT3 or overexpression of PTEN suppressed tumor growth and metastasis in nude mice. This study demonstrated that hypoxia augments activity and malignant behaviors of colorectal cancer cells through the STAT3/miR-19a/PTEN/PI3K/AKT axis.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] MicroRNA-4485 ameliorates severe influenza pneumonia via inhibition of the STAT3/PI3K/AKT signaling pathway
    Guo, Longfei
    Wang, Quanhong
    Zhang, Dongquan
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [42] GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
    He, Junbo
    Wang, Liangzhi
    Lv, Mengjia
    Yuan, Yiming
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [43] MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis
    Zhang, Ningrong
    Zang, Li
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2024, 22 (05) : 217 - 228
  • [44] MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways
    Selvakumar, Sushmaa Chandralekha
    Preethi, K. Auxzilia
    Sekar, Durairaj
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [45] NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K–AKT and JAK–STAT3 pathways
    Haluk Yuzugullu
    Thanh Von
    Lauren M Thorpe
    Sarah R Walker
    Thomas M Roberts
    David A Frank
    Jean J Zhao
    Cell Discovery, 2
  • [46] Rosmanol induces breast cancer cells apoptosis by regulating PI3K/AKT and STAT3/JAK2 signaling pathways
    Jiang, Dongjun
    Xu, Jiaqi
    Liu, Sitong
    Nasser, Moussa
    Wei, Wei
    Mao, Tianjiao
    Liu, Xintong
    Zou, Xiaopan
    Li, Jiang
    Li, Xiaomeng
    ONCOLOGY LETTERS, 2021, 22 (02)
  • [47] LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway
    陶绍能
    ChinaMedicalAbstracts(InternalMedicine), 2024, 41 (02) : 104 - 105
  • [48] Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway
    Yin, Qin
    Wang, Sen
    Yang, Jie
    Fan, Cunyu
    Yu, Yihan
    Li, Juan
    Mei, Feng
    Zhang, Shiwei
    Xi, Rengang
    Zhang, Xiuyun
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (08) : 1100 - 1110
  • [49] Leukemia inhibitory factor prevents chicken follicular atresia through PI3K/AKT and Stat3 signaling pathways
    Dong, Juan
    Guo, Changquan
    Zhou, Shuo
    Zhao, An
    Li, Jian
    Mi, Yuling
    Zhang, Caiqiao
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 543
  • [50] Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway
    Zhang, Ye
    Liu, Xinxin
    Zhang, Junying
    Xu, Yuanyuan
    Shao, Jie
    Hu, Yue
    Shu, Peng
    Cheng, Haibo
    AGING-US, 2020, 12 (07): : 5640 - 5650